The U.S. Supreme Court will hear arguments on Monday in a case that could limit consumers' ability to sue companies for failing to warn about product risks, specifically focusing on glyphosate, the active ingredient in Bayer's herbicide Roundup. Meanwhile, the U.S. House is expected to take up the farm bill this week, which includes new protections for glyphosate, putting the Make America Healthy Again (MAHA) movement at odds with President Donald Trump and most Republicans in Congress.
Part 1: Immediate Action & Core Facts
The Supreme Court case, Monsanto Company v. Durnell, will determine whether federal law preempts state-level lawsuits alleging glyphosate causes cancer. The EPA has classified glyphosate as "unlikely" to be carcinogenic, while the World Health Organization's International Agency for Research on Cancer (IARC) labeled it a "probable human carcinogen" in 2015. The farm bill, set for a House vote, includes provisions that would shield glyphosate from further legal challenges.
Part 2: Deeper Dive & Context
Legal and Scientific Context
The case hinges on whether the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts state lawsuits if the EPA has not required cancer warnings. Bayer argues that the EPA's approval of glyphosate should shield it from liability. Monsanto has faced over 100,000 lawsuits alleging Roundup caused cancer, with many cases resulting in multimillion-dollar settlements.
Political Implications
The MAHA movement, which endorsed Trump after Robert F. Kennedy Jr. dropped out of the presidential race, opposes glyphosate due to health concerns. The movement's advocates, including Kelly Ryerson, have criticized Trump's executive order boosting glyphosate production and his administration's support for Bayer in the Supreme Court case. The farm bill's passage could further strain the relationship between MAHA and Republicans ahead of the 2026 midterm elections.
Industry and Public Health Perspectives
Bayer and Syngenta, another pesticide manufacturer, argue that excessive warnings could confuse consumers. The EPA has repeatedly approved glyphosate for use, citing its safety, while health advocates point to studies linking glyphosate to cancer and other health issues. The Supreme Court's decision could set a precedent for future pesticide litigation.
Public Response
MAHA advocates plan to rally outside the Supreme Court on April 27, protesting the Trump administration's handling of glyphosate. The rally, titled "People vs. Poison," aims to highlight the health risks associated with the chemical and push for stricter regulations.